Peter C. Baker

730 total citations
44 papers, 578 citations indexed

About

Peter C. Baker is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Peter C. Baker has authored 44 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 9 papers in Endocrine and Autonomic Systems. Recurrent topics in Peter C. Baker's work include Neurotransmitter Receptor Influence on Behavior (18 papers), Neuroscience and Neuropharmacology Research (13 papers) and Circadian rhythm and melatonin (9 papers). Peter C. Baker is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (18 papers), Neuroscience and Neuropharmacology Research (13 papers) and Circadian rhythm and melatonin (9 papers). Peter C. Baker collaborates with scholars based in United States, India and Russia. Peter C. Baker's co-authors include W. B. Quay, Julius Axelrod, Cecilie A. Goodrich, David M. Spiegel, T R Price, S K Babcock, Hayato Kan, Keith A. Johnson, P.J. Spencer and Jacques P.J. Maurissen and has published in prestigious journals such as Nature, Brain Research and Developmental Biology.

In The Last Decade

Peter C. Baker

43 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C. Baker United States 13 302 186 147 75 57 44 578
José M. Rodríguez Ferrer Spain 14 229 0.8× 208 1.1× 131 0.9× 123 1.6× 23 0.4× 33 677
Francisco Javier Escalada San Martín Spain 15 280 0.9× 113 0.6× 141 1.0× 87 1.2× 71 1.2× 32 560
J. Julesz Hungary 16 267 0.9× 229 1.2× 85 0.6× 57 0.8× 190 3.3× 56 792
Wurtman Rj United States 9 156 0.5× 129 0.7× 73 0.5× 251 3.3× 34 0.6× 13 547
Bryant Benson United States 14 118 0.4× 138 0.7× 221 1.5× 78 1.0× 37 0.6× 49 620
P. Placheta Austria 12 402 1.3× 268 1.4× 24 0.2× 140 1.9× 21 0.4× 33 659
Scheving Le United States 10 109 0.4× 73 0.4× 261 1.8× 136 1.8× 34 0.6× 33 512
F Halberg United States 14 140 0.5× 118 0.6× 305 2.1× 165 2.2× 70 1.2× 66 825
Camila P. Almeida-Suhett United States 13 185 0.6× 231 1.2× 47 0.3× 94 1.3× 33 0.6× 16 682
Beatrix H. White United States 11 155 0.5× 198 1.1× 134 0.9× 69 0.9× 28 0.5× 18 394

Countries citing papers authored by Peter C. Baker

Since Specialization
Citations

This map shows the geographic impact of Peter C. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Baker more than expected).

Fields of papers citing papers by Peter C. Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Baker. The network helps show where Peter C. Baker may publish in the future.

Co-authorship network of co-authors of Peter C. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Baker. A scholar is included among the top collaborators of Peter C. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Baker. Peter C. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Keith A., Peter C. Baker, Hayato Kan, et al.. (2005). Diethylene glycol monobutyl ether (DGBE): two- and thirteen-week oral toxicity studies in Fischer 344 rats. Food and Chemical Toxicology. 43(3). 467–481. 10 indexed citations
2.
Warren, Alessandra, et al.. (1998). A relationship between myometrial resistance artery behaviour and circulating lipid composition?. Journal of the Society for Gynecologic Investigation. 5(1). 147A–147A. 4 indexed citations
3.
Spiegel, David M., et al.. (1995). Hemodialysis urea rebound: The effect of increasing dialysis efficiency. American Journal of Kidney Diseases. 25(1). 26–29. 41 indexed citations
4.
Baker, Peter C., et al.. (1991). The effects of acute and extended monoamine oxidase inhibition upon 5-hydroxyindoles in maturing mouse brain. General Pharmacology The Vascular System. 22(2). 347–352. 1 indexed citations
5.
Baker, Peter C., et al.. (1990). Chronic citalopram action and the maturing mouse brain's indoleamine levels. General Pharmacology The Vascular System. 21(5). 703–707. 3 indexed citations
6.
Baker, Peter C.. (1988). Indoleamine stores in maturing mouse brain reexposed to citalopram following extended uptake inhibition. General Pharmacology The Vascular System. 19(6). 819–823. 1 indexed citations
7.
Baker, Peter C., et al.. (1987). Indoleamine metabolism in maturing mouse brain following extended uptake inhibition with citalopram. General Pharmacology The Vascular System. 18(5). 467–471. 4 indexed citations
8.
Baker, Peter C., et al.. (1986). Effects of prenatal exposure to lithium on indoleamines in maturing mouse brain. General Pharmacology The Vascular System. 17(1). 101–103. 1 indexed citations
9.
Baker, Peter C., et al.. (1978). Exogenous melatonin and melanophore development inXenopus. Cellular and Molecular Life Sciences. 34(11). 1521–1522. 4 indexed citations
10.
Baker, Peter C., et al.. (1977). Effects of parachlorophenylalanine on indoleamines in maturing mouse brain. General Pharmacology The Vascular System. 8(3). 213–215. 6 indexed citations
11.
Baker, Peter C., et al.. (1976). Effects of inhibitors during eye indoleamine maturation. General Pharmacology The Vascular System. 7(1). 71–73. 1 indexed citations
12.
Baker, Peter C., et al.. (1975). The effects of LSD upon brain indoleamine maturation in the brain of the mouse. General Pharmacology The Vascular System. 6(1). 19–22. 2 indexed citations
13.
Baker, Peter C., et al.. (1974). The maturation of indoleamine metabolism in the lateral eye of the mouse. Comparative Biochemistry and Physiology Part A Physiology. 49(2). 281–286. 14 indexed citations
14.
Baker, Peter C., et al.. (1974). Free tryptophan levels in regions of the maturing mouse brain. Brain Research. 73(2). 376–379. 11 indexed citations
15.
Goodrich, Cecilie A., et al.. (1974). The maturational effects of LSD upon brain weight and behavior in the mouse. Comparative and General Pharmacology. 5(2). 153–155. 1 indexed citations
16.
Baker, Peter C., et al.. (1971). Melatonin localization in the eyes of larval Xenopus. Comparative Biochemistry and Physiology Part A Physiology. 39(4). 879–881. 27 indexed citations
17.
Baker, Peter C.. (1969). Melatonin levels in developing Xenopus laevis. Comparative Biochemistry and Physiology. 28(3). 1387–1393. 14 indexed citations
18.
Baker, Peter C. & W. B. Quay. (1969). 5-Hydroxytryptamine metabolism in early embryogenesis, and the development of brain and retinal tissues. A review. Brain Research. 12(2). 273–295. 109 indexed citations
19.
Baker, Peter C.. (1966). Monoamine oxidase in the eye, brain, and whole embryo of developing Xenopus laevis. Developmental Biology. 14(2). 267–277. 31 indexed citations
20.
Axelrod, Julius, W. B. Quay, & Peter C. Baker. (1965). Enzymatic Synthesis of the Skin-lightening Agent, Melatonin, in Amphibians. Nature. 208(5008). 386–386. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026